NO20043610L - Fenylpyrimidinaminer som IgE inhibitorer - Google Patents
Fenylpyrimidinaminer som IgE inhibitorerInfo
- Publication number
- NO20043610L NO20043610L NO20043610A NO20043610A NO20043610L NO 20043610 L NO20043610 L NO 20043610L NO 20043610 A NO20043610 A NO 20043610A NO 20043610 A NO20043610 A NO 20043610A NO 20043610 L NO20043610 L NO 20043610L
- Authority
- NO
- Norway
- Prior art keywords
- phenylpyrimidinamines
- ige inhibitors
- ige
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0202381A GB0202381D0 (en) | 2002-02-01 | 2002-02-01 | Organic compounds |
| GB0221953A GB0221953D0 (en) | 2002-09-20 | 2002-09-20 | Organic compounds |
| PCT/EP2003/000973 WO2003063871A1 (en) | 2002-02-01 | 2003-01-31 | Phenylpyrimidine amines as ige inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20043610L true NO20043610L (no) | 2004-10-05 |
Family
ID=27665364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20043610A NO20043610L (no) | 2002-02-01 | 2004-08-30 | Fenylpyrimidinaminer som IgE inhibitorer |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20050119255A1 (de) |
| EP (1) | EP1474146B1 (de) |
| JP (1) | JP4393198B2 (de) |
| KR (1) | KR20040081159A (de) |
| CN (2) | CN101684097A (de) |
| AR (1) | AR038368A1 (de) |
| AT (1) | ATE406165T1 (de) |
| AU (1) | AU2003206810B2 (de) |
| BR (1) | BR0307379A (de) |
| CA (1) | CA2471883C (de) |
| DE (1) | DE60323205D1 (de) |
| EC (1) | ECSP045213A (de) |
| ES (1) | ES2312749T3 (de) |
| IL (1) | IL162766A0 (de) |
| MX (1) | MXPA04007395A (de) |
| NO (1) | NO20043610L (de) |
| NZ (1) | NZ534229A (de) |
| PE (1) | PE20030983A1 (de) |
| PL (1) | PL370666A1 (de) |
| PT (1) | PT1474146E (de) |
| RU (1) | RU2004126614A (de) |
| TW (1) | TW200302728A (de) |
| WO (1) | WO2003063871A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
| CA2533474A1 (en) * | 2003-07-30 | 2005-02-10 | Shudong Wang | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| JPWO2005040135A1 (ja) * | 2003-10-24 | 2007-03-08 | 小野薬品工業株式会社 | 抗ストレス薬およびその医薬用途 |
| EP1933839A1 (de) | 2005-09-29 | 2008-06-25 | Novartis AG | Phenyl-(4-phenyl-pyrimidin-2-yl)-amine für erhöhte immuntoleranz |
| EP2195328A4 (de) * | 2007-08-15 | 2011-06-15 | Cytokinetics Inc | Bestimmte chemische einheiten, zusammensetzungen und verfahren |
| CA3162388A1 (en) | 2019-12-20 | 2021-06-24 | Alfredo C. Castro | 4-phenyl-n-(phenyl)thiazol-2-amine derivatives and related compounds as aryl hydrocarbon receptor (ahr) agonists for the treatment of e.g. angiogenesis implicated or inflammatory disorder |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1185039A (en) | 1966-03-31 | 1970-03-18 | Ici Ltd | Pyrimidine Derivatives and Compositions containing them |
| GB2001069B (en) | 1977-07-12 | 1982-01-20 | Scras | Pyrimidine derivatives |
| AU5319479A (en) | 1978-12-22 | 1980-06-26 | Ici Australia Limited | Pyrimidinyl amino phenoxy carboxylate derivatives |
| US4351939A (en) | 1980-10-16 | 1982-09-28 | Mead Johnson & Company | Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process |
| DE3270906D1 (en) | 1982-01-14 | 1986-06-05 | Merck Patent Gmbh | Liquid crystal mixtures |
| FR2536071B1 (fr) | 1982-11-12 | 1986-07-11 | Sanofi Sa | Sels acides de 2-piperazinopyrimidine, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2547821B1 (fr) | 1983-06-24 | 1985-12-06 | Sanofi Sa | Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant |
| US4659363A (en) | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
| EP0164204A1 (de) | 1984-05-12 | 1985-12-11 | FISONS plc | Pharmazeutisch nützliche Pyrimidine |
| ATE60591T1 (de) | 1984-06-25 | 1991-02-15 | Ciba Geigy Ag | Pyrimidinderivate wirksam als schaedlingsbekaempfungsmittel. |
| ATE135699T1 (de) | 1986-01-13 | 1996-04-15 | American Cyanamid Co | 4,5,6-substituierte 2-pyrimidinamine |
| DE3614060A1 (de) | 1986-04-23 | 1987-10-29 | Schering Ag | Pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| EP0254259A3 (de) | 1986-07-21 | 1989-11-23 | Otsuka Pharmaceutical Factory, Inc. | p-Aminophenol-Derivate |
| DE3788494D1 (de) | 1986-10-13 | 1994-01-27 | Ciba Geigy | Harnstoffe. |
| US4826990A (en) | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
| US4966622A (en) | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
| US4973690A (en) | 1988-04-12 | 1990-11-27 | Ciba-Geigy Corporation | Novel ureas |
| ATE92051T1 (de) | 1988-04-12 | 1993-08-15 | Ciba Geigy Ag | Harnstoffe. |
| JPH02308248A (ja) | 1989-05-24 | 1990-12-21 | Fuji Photo Film Co Ltd | アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
| US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| US5516775A (en) | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
| AU693475B2 (en) | 1993-10-01 | 1998-07-02 | Novartis Ag | Pyrimidineamine derivatives and processes for the preparation thereof |
| ATE208772T1 (de) | 1993-10-01 | 2001-11-15 | Novartis Erfind Verwalt Gmbh | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung |
| AU693114B2 (en) | 1993-10-01 | 1998-06-25 | Novartis Ag | Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| CZ101496A3 (en) * | 1993-10-12 | 1996-11-13 | Du Pont Merck Pharma | N-alkyl-n-aryl-pyrimidinamines and derivatives thereof |
| US5750531A (en) | 1994-08-13 | 1998-05-12 | Yuhan Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| AR038955A1 (es) | 1996-12-05 | 2005-02-02 | Amgen Inc | Compuestos de pirimidinona y piridona sustituidos y metodos para su uso |
| ES2203937T3 (es) * | 1997-03-26 | 2004-04-16 | Taisho Pharmaceutical Co., Ltd | Derivados de 4-tetrahidropiridilpirimidina. |
| IN188411B (de) | 1997-03-27 | 2002-09-21 | Yuhan Corp | |
| US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| WO1999035140A1 (en) * | 1998-01-12 | 1999-07-15 | Novartis Ag | PYRIDINYLPYRIMIDINE AMINES AS IMMUNOGLOBULINE E (IgE) SYNTHESIS INHIBITORS |
| CN1231440C (zh) * | 1998-01-28 | 2005-12-14 | 盐野义制药株式会社 | 新的三环化合物 |
| AU751573C (en) | 1998-03-27 | 2003-10-09 | Janssen Pharmaceutica N.V. | HIV inhibiting pyrimidine derivatives |
| TWI241298B (en) | 1998-09-25 | 2005-10-11 | Mitsubishi Chem Corp | Pyrimidone derivatives |
| HUP0104171A3 (en) * | 1998-11-17 | 2002-04-29 | Ihara Chemical Ind Co | Pyrimidinylbenzimidazole and triatinylbenzimidazole derivatives, intermediates and use as agricultura/horticultural fungicides |
| GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
| ATE365158T1 (de) | 1999-04-28 | 2007-07-15 | Inst Med Molecular Design Inc | Pyrimidincarbonsäurederivate |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-01-30 AR ARP030100267A patent/AR038368A1/es not_active Application Discontinuation
- 2003-01-30 TW TW092102250A patent/TW200302728A/zh unknown
- 2003-01-31 CA CA2471883A patent/CA2471883C/en not_active Expired - Fee Related
- 2003-01-31 JP JP2003563561A patent/JP4393198B2/ja not_active Expired - Fee Related
- 2003-01-31 US US10/501,445 patent/US20050119255A1/en not_active Abandoned
- 2003-01-31 ES ES03704506T patent/ES2312749T3/es not_active Expired - Lifetime
- 2003-01-31 CN CN200910205037A patent/CN101684097A/zh active Pending
- 2003-01-31 PL PL03370666A patent/PL370666A1/xx not_active Application Discontinuation
- 2003-01-31 RU RU2004126614/04A patent/RU2004126614A/ru not_active Application Discontinuation
- 2003-01-31 PT PT03704506T patent/PT1474146E/pt unknown
- 2003-01-31 EP EP03704506A patent/EP1474146B1/de not_active Expired - Lifetime
- 2003-01-31 NZ NZ534229A patent/NZ534229A/en unknown
- 2003-01-31 WO PCT/EP2003/000973 patent/WO2003063871A1/en active IP Right Grant
- 2003-01-31 DE DE60323205T patent/DE60323205D1/de not_active Expired - Fee Related
- 2003-01-31 AU AU2003206810A patent/AU2003206810B2/en not_active Ceased
- 2003-01-31 BR BR0307379-3A patent/BR0307379A/pt not_active IP Right Cessation
- 2003-01-31 MX MXPA04007395A patent/MXPA04007395A/es active IP Right Grant
- 2003-01-31 CN CNA038027372A patent/CN1622807A/zh active Pending
- 2003-01-31 PE PE2003000116A patent/PE20030983A1/es not_active Application Discontinuation
- 2003-01-31 IL IL16276603A patent/IL162766A0/xx unknown
- 2003-01-31 KR KR10-2004-7011797A patent/KR20040081159A/ko not_active Application Discontinuation
- 2003-01-31 AT AT03704506T patent/ATE406165T1/de active
-
2004
- 2004-07-30 EC EC2004005213A patent/ECSP045213A/es unknown
- 2004-08-30 NO NO20043610A patent/NO20043610L/no not_active Application Discontinuation
-
2007
- 2007-05-23 US US11/805,515 patent/US7759357B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR0307379A (pt) | 2004-12-28 |
| CA2471883C (en) | 2010-12-07 |
| CA2471883A1 (en) | 2003-08-07 |
| WO2003063871A1 (en) | 2003-08-07 |
| EP1474146A1 (de) | 2004-11-10 |
| ECSP045213A (es) | 2004-09-28 |
| EP1474146B1 (de) | 2008-08-27 |
| US20070281956A1 (en) | 2007-12-06 |
| JP2005516051A (ja) | 2005-06-02 |
| AU2003206810B2 (en) | 2006-06-29 |
| IL162766A0 (en) | 2005-11-20 |
| TW200302728A (en) | 2003-08-16 |
| CN101684097A (zh) | 2010-03-31 |
| PE20030983A1 (es) | 2004-01-26 |
| KR20040081159A (ko) | 2004-09-20 |
| RU2004126614A (ru) | 2005-05-27 |
| ATE406165T1 (de) | 2008-09-15 |
| CN1622807A (zh) | 2005-06-01 |
| NZ534229A (en) | 2005-04-29 |
| JP4393198B2 (ja) | 2010-01-06 |
| DE60323205D1 (en) | 2008-10-09 |
| PT1474146E (pt) | 2008-12-05 |
| US20050119255A1 (en) | 2005-06-02 |
| ES2312749T3 (es) | 2009-03-01 |
| AR038368A1 (es) | 2005-01-12 |
| PL370666A1 (en) | 2005-05-30 |
| US7759357B2 (en) | 2010-07-20 |
| MXPA04007395A (es) | 2005-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1492785T3 (da) | 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer | |
| NO20055680D0 (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| NO20044654L (no) | Piperidinoylpiperidiner som 5-HTIF-agonister | |
| DE602004018837D1 (de) | Ptidase-iv-inhibitoren | |
| ATE457980T1 (de) | Aryloxime | |
| ATE534648T1 (de) | C-6-modifizierte indazolylpyrrolotriazine | |
| ATE318817T1 (de) | Aza-arylpiperazine | |
| ATE427876T1 (de) | Luftkissenboot | |
| ATE349458T1 (de) | Etonogestrelester | |
| DK1492934T3 (da) | Dørenhed | |
| ATA1572002A (de) | Managementspleisskassette | |
| DK1499622T3 (da) | Meterotricyclyl-6-alkylidenpenemer som beta-lactamaseinhibitorer | |
| ATE373648T1 (de) | Nf-kappab-inhibitoren | |
| NO20043610L (no) | Fenylpyrimidinaminer som IgE inhibitorer | |
| ATE469773T1 (de) | Zugöse | |
| ATA19152002A (de) | Hubkupplung | |
| ATE396192T1 (de) | N-sulfonylaminothiazole | |
| ITMI20021327A1 (it) | Nuove ossialchilpiperazine | |
| DE10244834B8 (de) | Suszeptometer | |
| ATA16872002A (de) | Zwischenstück | |
| AT5889U3 (de) | Brennholzspleisser | |
| DE10211707A8 (de) | Segmentstatormaschine | |
| NO20044043L (no) | Dipyridodiazepioner som revers-transkriptase-inhibitorer | |
| NO20043433L (no) | Fremgangsmate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |